2019
DOI: 10.1016/j.biopha.2018.12.146
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic applications of selenium nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
412
0
13

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 601 publications
(436 citation statements)
references
References 97 publications
11
412
0
13
Order By: Relevance
“…Based on the results obtained from pancreatic enzyme secretions, biochemical parameters, histopathology, and immunostaining, we report that crocin is effective in protecting the pancreas from cerulein‐induced AP and regular intake of saffron in diet can significantly reduce the risk of AP. In future, novel formulations for the delivery of crocin may improve the chances of clinical translation of crocin (Khurana & Godugu, ; Khurana, Tekula, Saifi, Venkatesh, & Godugu, ).…”
Section: Discussionmentioning
confidence: 99%
“…Based on the results obtained from pancreatic enzyme secretions, biochemical parameters, histopathology, and immunostaining, we report that crocin is effective in protecting the pancreas from cerulein‐induced AP and regular intake of saffron in diet can significantly reduce the risk of AP. In future, novel formulations for the delivery of crocin may improve the chances of clinical translation of crocin (Khurana & Godugu, ; Khurana, Tekula, Saifi, Venkatesh, & Godugu, ).…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, different metallic nanoparticles (NPs) including silver (Ag) [4][5][6], gold (Au) [7], zinc (Zn) [8], selenium (Se) [9,10], titanium [11], ceria [12] have been explored [13]. Se is an essential metalloid element that has been extensively used in medical applications owing to its antioxidative, antimicrobial and antitumor activities [14]. Unlike other metallic NPs, Se is required by humans in trace amounts as a micronutrient.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, detailed toxicological studies are necessary to decide the clinical future of this novel plant and its various active constituents as safety is a critical concern during clinical development of plant‐based medicines (Izzo, Hoon‐Kim, Radhakrishnan, & Williamson, ). In addition, physiological and biopharmaceutical parameters are often the bottleneck in the clinical translation of plant‐based medicines, which may be addressed by using various novel formulation‐based strategies (Bale, Khurana, Reddy, Singh, & Godugu, ; Godugu, Kumari, & Khurana, ; Khurana et al, ; Khurana, Saifi, & Godugu, ; Khurana, Tekula, Saifi, Venkatesh, & Godugu, ).…”
Section: Resultsmentioning
confidence: 99%